nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—OPRM1—nicotine dependence	0.925	1	CbGaD
Nalbuphine—Dysphoria—Varenicline—nicotine dependence	0.00655	0.106	CcSEcCtD
Nalbuphine—Hostility—Varenicline—nicotine dependence	0.00512	0.0831	CcSEcCtD
Nalbuphine—Delusion—Varenicline—nicotine dependence	0.004	0.065	CcSEcCtD
Nalbuphine—Euphoric mood—Varenicline—nicotine dependence	0.00244	0.0396	CcSEcCtD
Nalbuphine—Cramp muscle—Varenicline—nicotine dependence	0.00185	0.0301	CcSEcCtD
Nalbuphine—Asthma—Varenicline—nicotine dependence	0.00178	0.0289	CcSEcCtD
Nalbuphine—Pollakiuria—Varenicline—nicotine dependence	0.00164	0.0267	CcSEcCtD
Nalbuphine—Depression—Varenicline—nicotine dependence	0.00158	0.0257	CcSEcCtD
Nalbuphine—Bradycardia—Varenicline—nicotine dependence	0.00145	0.0235	CcSEcCtD
Nalbuphine—Hallucination—Varenicline—nicotine dependence	0.00142	0.023	CcSEcCtD
Nalbuphine—Hypoaesthesia—Varenicline—nicotine dependence	0.00142	0.023	CcSEcCtD
Nalbuphine—Butorphanol—OPRM1—nicotine dependence	0.00131	0.142	CrCbGaD
Nalbuphine—Methylnaltrexone—OPRM1—nicotine dependence	0.00131	0.142	CrCbGaD
Nalbuphine—Erythema—Varenicline—nicotine dependence	0.00124	0.0201	CcSEcCtD
Nalbuphine—Dysgeusia—Varenicline—nicotine dependence	0.00121	0.0197	CcSEcCtD
Nalbuphine—Muscle spasms—Varenicline—nicotine dependence	0.00119	0.0193	CcSEcCtD
Nalbuphine—Vision blurred—Varenicline—nicotine dependence	0.00117	0.019	CcSEcCtD
Nalbuphine—Tremor—Varenicline—nicotine dependence	0.00116	0.0189	CcSEcCtD
Nalbuphine—Agitation—Varenicline—nicotine dependence	0.00114	0.0185	CcSEcCtD
Nalbuphine—Vertigo—Varenicline—nicotine dependence	0.00111	0.0181	CcSEcCtD
Nalbuphine—Syncope—Varenicline—nicotine dependence	0.00111	0.018	CcSEcCtD
Nalbuphine—Dihydrocodeine—OPRM1—nicotine dependence	0.00111	0.121	CrCbGaD
Nalbuphine—Loss of consciousness—Varenicline—nicotine dependence	0.00109	0.0177	CcSEcCtD
Nalbuphine—Convulsion—Varenicline—nicotine dependence	0.00107	0.0174	CcSEcCtD
Nalbuphine—Hypertension—Varenicline—nicotine dependence	0.00107	0.0174	CcSEcCtD
Nalbuphine—Anxiety—Varenicline—nicotine dependence	0.00105	0.0171	CcSEcCtD
Nalbuphine—Dry mouth—Varenicline—nicotine dependence	0.00103	0.0168	CcSEcCtD
Nalbuphine—Oedema—Varenicline—nicotine dependence	0.00101	0.0164	CcSEcCtD
Nalbuphine—Shock—Varenicline—nicotine dependence	0.000995	0.0162	CcSEcCtD
Nalbuphine—Tachycardia—Varenicline—nicotine dependence	0.000987	0.016	CcSEcCtD
Nalbuphine—Hyperhidrosis—Varenicline—nicotine dependence	0.000977	0.0159	CcSEcCtD
Nalbuphine—Naltrexone—OPRM1—nicotine dependence	0.000974	0.106	CrCbGaD
Nalbuphine—Oxymorphone—OPRM1—nicotine dependence	0.000974	0.106	CrCbGaD
Nalbuphine—Hypotension—Varenicline—nicotine dependence	0.000945	0.0153	CcSEcCtD
Nalbuphine—Dyspnoea—Varenicline—nicotine dependence	0.000901	0.0146	CcSEcCtD
Nalbuphine—Somnolence—Varenicline—nicotine dependence	0.000899	0.0146	CcSEcCtD
Nalbuphine—Dyspepsia—Varenicline—nicotine dependence	0.00089	0.0145	CcSEcCtD
Nalbuphine—Feeling abnormal—Varenicline—nicotine dependence	0.000833	0.0135	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Varenicline—nicotine dependence	0.000827	0.0134	CcSEcCtD
Nalbuphine—Urticaria—Varenicline—nicotine dependence	0.000803	0.013	CcSEcCtD
Nalbuphine—Body temperature increased—Varenicline—nicotine dependence	0.000799	0.013	CcSEcCtD
Nalbuphine—Abdominal pain—Varenicline—nicotine dependence	0.000799	0.013	CcSEcCtD
Nalbuphine—Oxycodone—OPRM1—nicotine dependence	0.000776	0.0846	CrCbGaD
Nalbuphine—Hypersensitivity—Varenicline—nicotine dependence	0.000745	0.0121	CcSEcCtD
Nalbuphine—Asthenia—Varenicline—nicotine dependence	0.000725	0.0118	CcSEcCtD
Nalbuphine—Buprenorphine—OPRM1—nicotine dependence	0.000715	0.078	CrCbGaD
Nalbuphine—Pruritus—Varenicline—nicotine dependence	0.000715	0.0116	CcSEcCtD
Nalbuphine—Naloxone—OPRM1—nicotine dependence	0.00071	0.0774	CrCbGaD
Nalbuphine—Hydromorphone—OPRM1—nicotine dependence	0.000705	0.0769	CrCbGaD
Nalbuphine—Dizziness—Varenicline—nicotine dependence	0.000669	0.0109	CcSEcCtD
Nalbuphine—Vomiting—Varenicline—nicotine dependence	0.000643	0.0104	CcSEcCtD
Nalbuphine—Rash—Varenicline—nicotine dependence	0.000638	0.0104	CcSEcCtD
Nalbuphine—Dermatitis—Varenicline—nicotine dependence	0.000637	0.0103	CcSEcCtD
Nalbuphine—Headache—Varenicline—nicotine dependence	0.000633	0.0103	CcSEcCtD
Nalbuphine—Nausea—Varenicline—nicotine dependence	0.000601	0.00976	CcSEcCtD
Nalbuphine—Morphine—OPRM1—nicotine dependence	0.0006	0.0653	CrCbGaD
Nalbuphine—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.000233	0.0576	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000219	0.0542	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.000204	0.0505	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000192	0.0475	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000162	0.0402	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000133	0.0328	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000116	0.0288	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00011	0.0271	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	9.83e-05	0.0243	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	9.6e-05	0.0237	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	9.24e-05	0.0228	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	8.57e-05	0.0212	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	8.1e-05	0.02	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	7.52e-05	0.0186	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	7.5e-05	0.0185	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	7.35e-05	0.0182	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	6.81e-05	0.0168	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	6.68e-05	0.0165	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	6.58e-05	0.0163	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	6.44e-05	0.0159	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	6.2e-05	0.0153	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	5.97e-05	0.0148	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	5.88e-05	0.0145	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	5.86e-05	0.0145	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	5.59e-05	0.0138	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	5.56e-05	0.0137	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	5.44e-05	0.0134	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	5.34e-05	0.0132	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	5.31e-05	0.0131	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	5.16e-05	0.0128	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	5.05e-05	0.0125	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	4.95e-05	0.0122	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	4.9e-05	0.0121	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	4.69e-05	0.0116	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	4.66e-05	0.0115	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	4.59e-05	0.0114	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	4.36e-05	0.0108	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	4.04e-05	0.01	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	4.02e-05	0.00994	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	3.96e-05	0.00979	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	3.94e-05	0.00973	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	3.55e-05	0.00877	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	3.53e-05	0.00872	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	3.16e-05	0.00781	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGD1—nicotine dependence	3.16e-05	0.0078	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	3e-05	0.00741	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	2.98e-05	0.00737	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	2.87e-05	0.0071	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	2.79e-05	0.00689	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	2.77e-05	0.00685	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGD1—nicotine dependence	2.77e-05	0.00684	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	2.52e-05	0.00622	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	2.44e-05	0.00604	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGD1—nicotine dependence	2.34e-05	0.00578	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	2.29e-05	0.00565	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	2.08e-05	0.00513	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	2.07e-05	0.00511	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	2e-05	0.00495	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—WASF2—nicotine dependence	1.96e-05	0.00486	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—WASF1—nicotine dependence	1.88e-05	0.00466	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	1.82e-05	0.0045	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—WASF2—nicotine dependence	1.72e-05	0.00426	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	1.7e-05	0.00419	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	1.69e-05	0.00419	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—WASF1—nicotine dependence	1.65e-05	0.00408	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	1.54e-05	0.0038	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	1.49e-05	0.00368	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—WASF2—nicotine dependence	1.46e-05	0.0036	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—WASF1—nicotine dependence	1.4e-05	0.00345	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—DRD2—nicotine dependence	1.23e-05	0.00303	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—DRD2—nicotine dependence	1.08e-05	0.00266	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—DRD2—nicotine dependence	9.09e-06	0.00225	CbGpPWpGaD
